Rapport Therapeutics, Inc. — Director's Dealing 2026

Feb 4, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Rapport Therapeutics, Inc. (RAPP)
CIK: 0002012593
Period of Report: 2026-02-02

Reporting Person: Sevigny Jeffrey (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-02	Stock Option (Right to Buy)	$27.75	A	130000	Acquired	2036-02-02	Common Stock (130000)	Direct

Footnotes

F1: The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2026, subject to the Reporting Person's continued service on each such vesting date.